Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?

Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the metabolic health beneficial products of the adipose tissue. Nevertheless, adiponectin has been shown to exert some extra beneficial non metab...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Michalakis Konstantinos G.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2020
Materias:
Acceso en línea:https://doaj.org/article/6ecbdc55af274949bbe32eea940fa2fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ecbdc55af274949bbe32eea940fa2fa
record_format dspace
spelling oai:doaj.org-article:6ecbdc55af274949bbe32eea940fa2fa2021-12-02T16:40:25ZEndocrine approach in the treatment of obesity: Is there any space for the adiponectin action?1336-032910.2478/enr-2020-0018https://doaj.org/article/6ecbdc55af274949bbe32eea940fa2fa2020-07-01T00:00:00Zhttps://doi.org/10.2478/enr-2020-0018https://doaj.org/toc/1336-0329Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the metabolic health beneficial products of the adipose tissue. Nevertheless, adiponectin has been shown to exert some extra beneficial non metabolic actions, as well. Adiponectin levels can be related to reduced incidence of cancer in obese patients. Moreover, adiponectin has been shown to be implicated in the positive fertility outcomes of women. Some new studies have also indicated that adiponectin has a potential effect in the control of appetite, which raises a question, whether adiponectin could be accredited to be useful in the endocrine evaluation of obesity. Could these additional non-metabolic actions prove its helpfulness?Michalakis Konstantinos G.Sciendoarticleadiponectinobesitynon metabolic actionsDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENEndocrine Regulations, Vol 54, Iss 3, Pp 157-159 (2020)
institution DOAJ
collection DOAJ
language EN
topic adiponectin
obesity
non metabolic actions
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle adiponectin
obesity
non metabolic actions
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Michalakis Konstantinos G.
Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?
description Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the metabolic health beneficial products of the adipose tissue. Nevertheless, adiponectin has been shown to exert some extra beneficial non metabolic actions, as well. Adiponectin levels can be related to reduced incidence of cancer in obese patients. Moreover, adiponectin has been shown to be implicated in the positive fertility outcomes of women. Some new studies have also indicated that adiponectin has a potential effect in the control of appetite, which raises a question, whether adiponectin could be accredited to be useful in the endocrine evaluation of obesity. Could these additional non-metabolic actions prove its helpfulness?
format article
author Michalakis Konstantinos G.
author_facet Michalakis Konstantinos G.
author_sort Michalakis Konstantinos G.
title Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?
title_short Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?
title_full Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?
title_fullStr Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?
title_full_unstemmed Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?
title_sort endocrine approach in the treatment of obesity: is there any space for the adiponectin action?
publisher Sciendo
publishDate 2020
url https://doaj.org/article/6ecbdc55af274949bbe32eea940fa2fa
work_keys_str_mv AT michalakiskonstantinosg endocrineapproachinthetreatmentofobesityisthereanyspacefortheadiponectinaction
_version_ 1718383579350695936